Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Abattis Bioceuticals Corp ATTBF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets... see more

GREY:ATTBF - Post Discussion

Abattis Bioceuticals Corp > Abattis Bioceuticals Pulls Itself Out of Penny Stocks
View:
Post by bogdansz on Oct 06, 2019 5:29pm

Abattis Bioceuticals Pulls Itself Out of Penny Stocks

Abattis Bioceuticals pulls itself out of penny stocks, produces revenue

Daily Hive  /  Oct 4 2019, 2:30 pm

Cannabis company Abattis Bioceuticals has managed to pull itself up out of the penny stock pages and has begun generating revenu

The company, which specializes in everything from cannabis cultivation to vaporizers to blockchain said recently they had managed to reach as high as $0.94 per share on heavy volume. Since then, according to a press release in September, Abattis has now shifted its focus to “revenue-generating business units.”

This year saw the launch of the company’s subsidiary Vergence’s product line. A suite of cannabis products designed to reduce pain and inflammation. The new products, combined with the acquisition of Pro Natura, an established nutraceutical company based in Oisterwijk, Netherlands, in April has the company feeling optimistic.

Abattis now says it’s on track for a seven-figure annualized revenue, unique for an industry in which many peers are generating zero revenue, “while continuing to hemorrhage significant amounts of cash.

In 2019, Abattis was ceased trading on the stock exchange due to its inability to file its financial statements for the previous fiscal year. According to a statement, this resulted in Abattis firing both its auditor and CFO, while also replacing the majority of its Board of Directors

Since then, Abattis has successfully filed its year-end financials and those for the subsequent quarters, allowing for it to again trade on the Canadian Stock Exchange

“The Company is completely focused on driving top-line revenue and maximizing efficiencies within its divisions in order to maximize profitability,” said President and CEO, Robert Abenante in a statement. “We will continue to grow the company through acquisitions, which focusing on organic growth in our revenue-generating businesses.”


Dailyhive
Comment by oilers99 on Oct 08, 2019 10:22am
Ummmmmm, huh!? What did I miss? When did this start trading again?
Abattis Bioceuticals Corp